ALX ONCOLOGY HOLDINGS INC (ALXO)

US00166B1052 - Common Stock

15.36  -1.26 (-7.58%)

After market: 15.36 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.001.18M4.80M
Cost Of Goods
N/A0.00N/A1.08M4.36M
Gross Profit
N/A0.00N/A110.00K440.00K
Operating Expenses
170.28M127.44M83.56M43.77M19.62M
Research and Development
141.79M98.40M60.17M28.96M16.31M
Selling, General, and Administrative Expenses
28.48M29.04M23.39M14.81M3.31M
Operating Income
-170.28M-127.44M-83.56M-43.66M-19.18M
Interest Income/Expense
9.08M4.28M-10.00K-810.00K-20.00K
Other Income/Expense
389.00K-260.00K80.00K-400.00K-10.00K
Non Recurring Items
N/A0.000.00-620.00KN/A
Income Before Taxes
-160.81M-123.42M-83.48M-45.50M-19.21M
Income Tax
0.0060.00K-20.00K240.00K30.00K
Net Income
-160.81M-123.48M-83.46M-50.94M-23.27M
EBITDA
-169.44M-127.10M-83.51M-43.46M-18.75M
 
Per Share Data
EPS Diluted Total Ops
-3.74-3.03-2.07-2.76-0.67
Non GAAP EPS
-3.75-3.03-2.06-4.48N/A
 
Statistics
Gross Profit Margin
N/AN/AN/A9.32%9.17%
Profit Margin
N/AN/AN/A-4316.95%-484.79%
Operating Profit Margin
N/AN/AN/A-3700.00%-399.58%

All data in USD

Charts